Introduction {#s1}
============

*Clostridium perfringens* is a Gram-positive, anaerobic, spore-forming bacterium found in various environments, especially in the gastrointestinal tract (GIT) of humans and animals ([@r023]; [@r028]). It is not a foodborne pathogen causing food poisoning, but also increases the risk of enterotoxaemia, gangrenous dermatitis and necrotic enteritis, especially in swine and poultry ([@r011]; [@r023]; [@r028]). *C. perfringens* produces various toxins (α, β, β2, ε, ι and the enterotoxin CPE) associated with the disease outbreaks ([@r003]; [@r025]; [@r027]).

With increased limitations on antibiotic use, the efficacy of alternatives such as bacteriocins and bacteriophages has been evaluated ([@r005]; [@r014]).

Bacteriocins are ribosomally synthesized peptides or proteins, which display a broad or narrow spectrum of antimicrobial activity. They show bactericidal action against several pathogenic bacteria and are widely regarded as natural bio-preservatives in food and feed industries ([@r010]; [@r012]).

Bacteriophages (phages) can also be used as effective alternatives to antibiotics for pathogen control ([@r021]). Bacteriophages are viruses that infect and replicate within the bacteria, leading to host lysis and cell death. Phages and their derivatives have emerged as natural bio-preservatives for the prevention, treatment, and eradication of pathogenic bacteria in a wide range of processing environments ([@r009]; [@r017]).

Therefore, in this study, we isolated a bacteriocin-producing strain and two bacteriophages from the feces of domestic animals and characterized their antimicrobial activities against *C. perfringens*. We determined their antimicrobial spectrum, conditions of activity and stability. In addition, the isolated bacteriocin and bacteriophages were evaluated for combined effects against *C. perfringens*. We investigated the probiotic effects of bacteriocin-producing bacteria and bacteriophages *in vitro* to develop potential candidates for probiotic use in domestic animals.

Materials and Methods {#s2}
=====================

Bacterial strains, bacteriophages and culture conditions {#s2a}
--------------------------------------------------------

Indicators used in this study were obtained from the Korean Collection for Type Culture (KCTC). Bacteriocin-producing bacteria were isolated from the feces of chickens and maintained at -80℃ in stock solution (skim milk and glycerol mixture). *Streptococcus hyointestinalis* strain was cultured in GM17 (M17 medium supplemented with 0.5% glucose). We isolated phages against *C. perfringens* from the feces and cecal contents of chickens and stored in saline magnesium buffer (SM buffer; 50 mM Tris-Cl, 100 mM NaCl, 8 mM MgSO~4~·7H~4~O, and gelatin 0.002% (w/v), pH 7.5).

Screening of bacteriocin-producing bacteria and bacteriophages targeting *C. perfringens* {#s2b}
-----------------------------------------------------------------------------------------

The fecal samples of chickens were collected from a poultry farm at Chung-Ang University. The pig fecal samples were collected from a local farm in Anseong, Gyeonggi-do, Republic of Korea. Fecal samples were isolated from 35-day-old Ross 308 broiler chickens, 38-week-old Hyline Brown laying hens, and 22-week-old Landrace pigs. Samples were used immediately for the screening of bacteriocin-producing bacteria and lytic bacteriophages.

Fresh fecal samples were serially diluted ten-fold with sterile anaerobic dilute solution (Na~2~HPO~4~ 6.0 g, KH~2~PO~4~ 4.5 g, L-cysteine 0.5 g, Tween 80 0.5 g per L) and plated on brain heart infusion (BHI) or lactobacilli MRS agar and incubated at 37℃ for 24 h under anaerobic conditions ([@r002]).

After incubation, 40 colonies (20 per medium) in each sample were randomly selected and inoculated into 5 mL of BHI or MRS broth ([@r013]). The isolates were incubated at 37℃, and centrifuged at 10,000 *g* for 10 min at 4℃. The supernatants were filtered with a 0.45 μm filter (Pall Life Sciences, USA) followed by testing for antagonistic activity against *C. perfringens* according to the spot-on-the-lawn method ([@r018]). The supernatants were serially diluted two-fold, and 10 μL of samples were spotted onto the surface of 0.7% BHI soft agar (1.25 mM CaCl~2~) inoculated with an overnight culture of *C. perfringens* KCTC 3269^T^ . After incubation at 37℃ for 24 h, the plates were checked for the inhibition zones.

After identification of inhibition zones against *C. perfringens*, the supernatants were adjusted to neutral pH and treated with proteinase K and catalase at a final concentration of 1 mg/mL (Sigma Chemical CO., USA) at 37℃ for 1h, followed by heating at 80℃ for 10 min to inactivate the enzymes and tested again for bacteriocin levels ([@r026]).

To isolate the bacteriophages, the fecal samples were mixed with BHI broth supplemented with 2 X CaCl~2~ and 2 X MgSO~4~ in the ratio 1 : 2. The mixture was inoculated with *C. perfringens* KCTC 3269^T^ and incubated at 37℃ for 48 h for preenrichment. After incubation, the sample was centrifuged at 10,000 rpm for 10 min at 4℃, and the supernatant was filtered.

The pre-enriched samples were processed using the double-layer method for phage propagation ([@r030]). Each double-layered plate contained 100 μL of samples and 100 μL of overnight incubated *C. perfringens* KCTC 3269^T^ and 4 mL of BHI soft agar (0.7%) on BHI agar. After incubation at 37℃ for 24 h, a single plaque was isolated from the plate and placed in 1 mL of SM buffer in an Eppendorf tube, and laid for 12 h at 4℃ to spread out. The buffer was centrifuged at 10,000 *g* for 10 min and the supernatant was filtered to eliminate the indicator. The filtered supernatant was propagated by the double-layer method ([@r004]; [@r022]).

Isolated phage titer was determined by spot-on-the-lawn method as described above. The propagated phages were serially diluted in SM buffer followed by the addition of 10 μL on the surface of soft BHI agar containing *C. perfringens*, and the titer was expressed as plaque forming units (PFU/mL).

Identification of bacteriocin-producing bacteria {#s2c}
------------------------------------------------

To identify the bacteriocin-producing bacteria, their DNA was isolated using a Powerfecal DNA isolation kit (MOBIO., USA) and the 16S rRNA gene was PCR-amplified using universal primers (27F and 1492R) followed by purification and sequencing (Solgent, Republic of Korea). The identified strains were confirmed and compared with BLAST in NCBI (Basic Local Aliments Search Tools in National Center for Biotechnology Information, USA).

Bacteriocin production during growth in BHI broth {#s2d}
-------------------------------------------------

The bacteriocin-producing strain was incubated in BHI broth (1% v/v) at 37℃, and the samples were removed at 2-h intervals to measure the antagonistic activity of bacteriocin. The bacteriocin activities were conducted by the spot-on-the-lawn method ([@r024]). Bacteriocin activity was expressed in terms of arbitrary units per mL (AU/mL), defined as the highest two-fold dilution showing definite inhibition of the indicator ([@r013]).

Inhibition spectrum of bacteriocins against other pathogens {#s2e}
-----------------------------------------------------------

To identify the inhibitory effects of bacteriocin against other pathogenic species, the bacteriocin-producing bacteria was serially diluted ten-fold with sterile 1X phosphate buffered saline (PBS; NaCl 8.0 g, KCl 0.2 g, Na~2~HPO~4~ 1.44 g, KH~2~PO~4~ 0.24 g per L), and spread onto GM17 agar plates. After incubation at 37°C for 24 h, they were overlaid on the soft agar (0.7%) with indicator organisms. After further incubation at 37°C for 18 h, we determined the inhibition zone around the colonies of bacteriocin-producing bacteria.

Partial purification of bacteriocin {#s2f}
-----------------------------------

The bacteriocin-producing *S. hyointestinalis* B19 strain was inoculated (1% v/v) in 1 L of GM17 broth at 37℃ for 15 h. The bacteria were removed by centrifugation at 10,000 *g* for 10 min at 4℃ followed by 0.45 μm filtration. The culture supernatant was precipitated at 40% saturation by the addition of fine-ground ammonium sulfate and stirred for 1 h at 4°C. After centrifugation at 10,000 *g* for 15 min at 4℃, the precipitate was resuspended in a low volume of 100 mM sodium phosphate buffer pH 6.5 ([@r029]). The precipitate solutions were dialyzed and concentrated by Amicon centrifugal filter (3 kDa molecular cut off, Merck Millipore Ltd, Germany). Each step was expressed in terms of AU/mL of inhibition zones of *C. perfringens* KCTC 3269^T^ ([@r015]; [@r029]).

Temperature and pH stability {#s2g}
----------------------------

To test for heat stability, the partially purified bacteriocin was heated at 25℃, 50℃, 90℃ for 1 h, or 121℃ for 15 min. To identify the effects of pH stability of bacteriocin, equal amounts of 2 M pH 2 (glycine-HCl), pH 4 (acetate), pH 6 (sodium phosphate), pH 8 (Tris), and pH 10 (glycine-NaOH) buffer were mixed, and incubated at 4℃ for 24 h ([@r015]). Any residual activity of the bacteriocin against *C. perfringens* KCTC 3269^T^ was determined by the spot-on-the-lawn method ([@r024]).

Lytic activity of bacteriophages against *C. perfringens* {#s2h}
---------------------------------------------------------

Lytic activities of the phages were evaluated by measuring the optical density (O.D.) during incubation of the mixtures containing *C. perfringens* and the phage. We incubated 3 mL of BHI broth with 1% (v/v) overnight cultured *C. perfringens* KCTC 3269^T^ (10^8^ CFU/mL) and 1% diluted phages at multiplicity of infection (MOI) values of 1.0 (10^8^ PFU/mL) and 0.1 (10^7^ PFU/mL). The mixtures were incubated at 37℃ under anaerobic conditions for 12 h and 0.2 mL samples were obtained in triplicate at 2 h intervals to measure O.D. values using a 96-well cell culture plate and a microplate reader (Molecular Devices LLC., USA) ([@r001]).

Combined effect of bacteriocin and bacteriophages {#s2i}
-------------------------------------------------

The combined effects of the isolated bacteriocin and phages were evaluated. The partially purified bacteriocin (1/2 diluted of desalted solutions) and P4, A3 phages (diluted to 10^8^ PFU/mL) were used in the combined effect test. We inoculated 5 mL of BHI broth with 50 μL (1%) of 10^8^ CFU/mL *C. perfringens* KCTC 3269^T^ followed by supplemental treatments. First, a single supplement was added including 150 μL (3%) of the bacteriocin, P4 phage, and A3 phage. Second, the mixture of bacteriocin and phages was supplemented with B19 (1%) bacteriocin and a cocktail of P4 (1%) and A3 (1%) phages. The total percentage of the added supplements was similar for all the treatments. The mixtures were incubated at 37℃ for 12 h under anaerobic conditions. Before and after incubation, 200 μL of the samples were extracted in triplicate for O.D. measurement at 600 nm. The viable cell counts of the residual *C. perfringens* were identified by diluting all the samples ten-fold with a 1 X PBS buffer, and spread on BHI agar followed by incubation at 37℃ for 24 h under anaerobic conditions ([@r016]; [@r017]).

To identify the antagonistic effect of the bacteriocin-producing bacteria and the combination of bacteria and lytic phages, a 5 mL of BHI broth was inoculated with 50 μL (1%) of 10^8^ CFU/mL overnight cultured *C. perfringens* KCTC 3269^T^ . We first added 50 μL (1%) of 10^7^ CFU/mL diluted *S. hyointestinalis* B19 to the BHI broth. We then added 50 μL (1%) of 10^7^ CFU/mL of overnight-cultured *S. hyointestinalis* B19 and 50 μL (1%) of each dilution to 10^8^ PFU/mL P4, A3 cocktail of the phages. The mixtures were incubated at 37℃ for 12 h under anaerobic conditions. The survival of *C. perfringens* was determined by plating decimal dilutions on plates of *C. perfringens* selective agar (Oxoid Ltd., UK.) and BHI agar ([@r017]).

Acid and bile tolerance test for probiotic traits {#s2j}
-------------------------------------------------

To test acid tolerance, the overnight culture of *S. hyointestinalis* B19 was centrifuged at 10,000 rpm for 10 min at 4℃ and washed with 1 X PBS buffer. It was harvested again and resuspended in 5 mL of the pH adjusted buffer to a final pH 2.0, 2.3, 2.5, 3.0, 4.0, 5.0 and 7.0 (control). The suspensions were incubated at 37℃ for 1 h, and the survival of *S. hyointestinalis* B19 was determined by the spread plate count on GM17 agar.

The bile tolerance test was conducted by spreading the overnight cultures of *S. hyointestinalis* B19 on GM17 agar containing bovine bile (Sigma, USA) at 0%, 0.5%, 1%, 2%, 3%, 4%, and 5%, respectively. The plates were incubated at 37℃ for 48 h ([@r007]; [@r013]).

Results {#s3}
=======

Isolation and identification of bacteriocin-producing bacteria {#s3a}
--------------------------------------------------------------

Among the 1,160 strains isolated from the fecal samples of chickens and pigs, 31 strains showed inhibitory activity against the indicator strains. The supernatants of these strains were neutralized with 1 M NaOH, and treated with enzymes such as catalase and proteinase. Three catalase-negative and proteinase-positive strains were selected, and one bacteriocin-producing strain against *C. perfringens* was finally selected.

The strain was identified by 16S rDNA sequencing and compared with BLAST in NCBI. The 16S rDNA sequence showed 99.09% similarity with that of *Streptococcus hyointestinalis* ATCC 49169^T^ . Therefore this strain was identified as *Streptococcus hyointestinalis* B19.

Bacteriocin production during growth phase {#s3b}
------------------------------------------

Bacteriocin production by *S. hyointestinalis* B19 in the BHI medium was detected at the beginning of 8 h growth time (200 AU/mL), which reached the maximum levels at 10 h (400 AU/mL; [Fig. 1](#f001){ref-type="fig"}).

![The bacteriocin production during the growth of *S. hyointestinalis* B19 in BHI broth.](kosfa-38-88-f001){#f001}

Inhibition spectrum of bacteriocins against other pathogens {#s3c}
-----------------------------------------------------------

The colonies of bacteriocin-producing bacteria were tested for their antimicrobial activities against a few Gram-positive and Gram-negative bacteria. Most of the selected *C. perfringens* and *Listeria monocytogenes* strains showed a strong inhibition zone around the colonies of bacteriocin-producing bacteria ([Fig. 2](#f002){ref-type="fig"}). However, the bacteriocins failed to inhibit all the tested Gram-negative strains (*Escherichia coli*, *Salmonella*, *Campylobacter* spp.) and Gram-positive *Staphylococcus aureus* strains ([Table 1](#t001){ref-type="table"}).

![Over-lay method showing the bacteriocin activity around the colonies of *S.hyointestinalis* B19 against *L. monocytogenes* KCTC 3569.](kosfa-38-88-f002){#f002}

Table 1.Antimicrobial spectrum of the isolated *S. hyointestinalis* B19 strains against some of pathogenic bacteria including five strains of *C. perfringens* (+ means showing positive inhibition effect to indicator bacteria; +++, very strong inhibition; ++, strong; +, a little inhibition)Indicator microorganisms*S. hyointestinalis* B19*Clostridium perfringens* KCTC 5100++*Clostridium perfringens* KCTC 5101-*Clostridium perfringens* KCTC 5102++*Clostridium perfringens* USDA+++*Clostridium perfringens* KCTC 3269T+++*Staphylococcus aureus* ATCC 33591-*Staphylococcus aureus* ATCC 27664-*Staphylococcus aureus* 35-*Listeria monocytogenes* ATCC 19114+++*Listeria monocytogenes* ATCC 19115+*Listeria monocytogenes* ATCC 7644+++*Listeria monocytogenes* KCTC 3569+++*Listeria monocytogenes* KCTC 13064+++*Campylobacter jejuni* ATCC 33291-*Campylobacter jejuni* ATCC 33560-*Escherichia coli* ATCC 43888-*Escherichia coli* YHS 394-*Escherichia coli* ATCC 25922-*Salmonella enteritidis* YHS 383-

Partial purification and concentration of bacteriocin {#s3d}
-----------------------------------------------------

The bacteriocin activity of the cell-free supernatant (1 L) obtained after culturing bacteriocin-producing bacteria was 400 AU/mL. Ammonium sulfate precipitation enhanced the bacteriocin activity to 12,800 AU/mL, and finally Amicon desalting and concentration resulted in 25,600 AU/mL activity ([Table 2](#t002){ref-type="table"}).

Table 2.Partial purification and concentration of the bacteriocin of *S. hyointestinalis* B19 from the supernatantVolume1 L40 mL4 mLStrain / purification stepCulture supernatantAmmonium sulfateAmicon desalting*S. hyointestinalis* B19400 AU/mL12,800 AU/mL25,600 AU/mL

Temperature and pH stability of bacteriocin {#s3e}
-------------------------------------------

The effects of heat and pH on the stability of bacteriocin were investigated. The partially purified bacteriocin was a heat-stable and pH-stable protein. These activities remained fully active at buffer pH 2, 4, 6 and 8 (3,200 AU/mL). At pH 10, the bacteriocin activity of the strain was reduced by 20% approximately (2,600 AU/mL; [Fig. 3](#f003){ref-type="fig"}).

![Effect of pH on the activities of the partially purified bacteriocin isolated from *S. hyointestinalis* B19.](kosfa-38-88-f003){#f003}

Bacteriocin (6,400 AU/mL) was fully stable during heat treatment at 4℃, 25℃, and 50℃. However, the activity was reduced by 50% (3,200 AU/mL; [Fig. 4](#f004){ref-type="fig"}) after heating at 90℃ and autoclaving at 121℃.

![Effect of heat treatments on the activities of the partial purified bacteriocin isolated from *S. hyointestinalis* B19.](kosfa-38-88-f004){#f004}

Isolation of bacteriophages against *Clostridium perfringens* {#s3f}
-------------------------------------------------------------

We isolated 10 phages (A1 to A6 and P1 to P4) against *C. perfringens* KCTC 3269^T^ . A1 to A6 phages were isolated from the feces of laying hens (Hyline Brown, 38-weeks-old) and P1 to P4 phages were isolated from the feces of pigs (Landrace, 22-weeks-old). All the isolated phages showed activities against *C. perfringens* KCTC 3269^T^ alone. These isolated phages were propagated by double-layer methods to reach 10^9^ PFU/mL. In this process, four phages, A1, A3, P2, and P4 were selected for further experiments (data not shown).

Evaluation of lytic activity of phages against *C. perfringens* {#s3g}
---------------------------------------------------------------

Lytic activities of the four phages were evaluated by measuring the increase in optical density (O.D.) of *C. perfringens* KCTC 3269^T^ using a 96-well microplate reader. All the treatments showed inhibition of *Clostridium perfringens* KCTC 3269^T^ growth compared with control (indicator only), however, the degrees of inhibition varied. After 12 h of incubation, P2 at MOI 1, P4 at MOI 1 and 0.1, and A3 at MOI 1 and 0.1 treatments completely (rate of O.D. increasing values less than 5%) inhibited the growth of *C. perfringens* compared with control. The P2 at MOI 0.1 treatment inhibited minimally (8.7% increase), while A4 phage treatments showed the lowest inhibition (MOI 1; 44.7%, MOI 0.1; 34.3% increase) ([Fig. 5](#f005){ref-type="fig"}).

![Lytic activities of selected four phages at MOI 0.1 and 1 incubated in BHI broth. Optical density(O.D.) increase in 600 nm wavelength of *C. perfringens* KCTC 3269^T^ at different incubated time intervals until 12 hours.](kosfa-38-88-f005){#f005}

Synergistic effect of bacteriocins and bacteriophages {#s3h}
-----------------------------------------------------

The combined effect of the isolated bacteriocin and phages was evaluated using the P4 and A3 phages in this experiment. The viable cell counts and O.D. measurements of the treated samples at 600 nm were evaluated simultaneously. After incubation for 12 h, the treatments with phages combined with bacteriocin, or phage and bacteriocin alone reduced the bacterial populations compared with control (indicator only). Treatments with the phage or bacteriocin alone reduced the bacterial populations by 3.80 (B19 bacteriocin alone) 1.36 (P4 phage alone) to 4.41 (A3 phage alone) log units. In comparison, the addition of phages and bacteriocin together reduced the bacterial populations by 6.20 (B19+P4+A3 treatment) log units. As the data reveal, combining the phages with bacteriocin resulted in higher inhibition compared with the phage or bacteriocin alone. The O.D. variation was almost similar across the bacterial populations ([Fig. 6](#f006){ref-type="fig"}). The antagonistic effect of *S. hyointestinalis* B19 strain alone and in combination with the bacteria and the lytic phages was evaluated. Treatment with *S. hyointestinalis* B19 reduced *C. perfringens* population from 8.58 to 3.85 log units. A second treatment with *S. hyointestinalis* B19 combined with P4 and A3 phages eradicated the bacterial populations completely. Further, the population of *S. hyointestinalis* B19 in the combined treatment with *C. perfringens* and *S. hyointestinalis* B19 was higher than in the treatment with *S. hyointestinalis* B19 strain alone ([Fig. 7](#f007){ref-type="fig"})

![The bacterial populations and optical density(O.D.) of *Clostridium perfringens* KCTC 3269^T^ After treatments with the phage alone(P4, A3), the partial purified bacteriocin alone(B19), and combination of the bacteriocin and phages for combined effect evaluation. Bar graph means the bacterial populations of *Clostridium perfringens* ; A line graph means the O.D. increasing after incubation.](kosfa-38-88-f006){#f006}

![The antagonistic effect of the bacteriocin-producing *S. hyointestinalis* B19 alone and the combination with the P4 and A3 phages. The population of *C. perfringens* KCTC 3269^T^ (bar) and *S. hyointestinalis* B19 (a line) in BHI broth at 37℃ for 12 hours.](kosfa-38-88-f007){#f007}

Acid and bile tolerance of *S. hyointstinalis* B19 {#s3i}
--------------------------------------------------

The bacteriocin-producing *S. hyointestinalis* B19 was stable until pH 4.0 (at pH 7, average 8.64 log unit; at pH 5, 8.48 and at Ph 4, 8.55 log units, however, the survival of the strain was not detected below pH 3.

*S. hyointestinalis* B19 was stable at a bile salt concentration up to 1% (containing 0%, average 9.63 log unit; 0.5%, 8.80 and 1%, 8.84 log units). At 2% and 3% bile concentration, CFU of *S. hyointestinalis* B19 decreased (containing 2%, 7.19 and 3%, 5.40 log units). Finally at 4 and 5 %, the cell counts were not detected.

Discussion {#s4}
==========

In this study, the bacteriocin-producing strain, *S. hyointestinalis* B19 and two lytic phages, P4 and A3 phages, were isolated from feces of chickens and pigs, and were found to exhibit antagonistic effects against *C. perfringens*.

The *S. hyointestinalis* strain was first reported in 1988 from the intestines of pigs ([@r006]). Recently, [@r019] characterized a novel bacteriocin, Nisin H, produced by a strain of *S. hyointestinalis* DPC6484 isolated from the porcine intestine. However, the isolated *S. hyointestinalis* B19 strain was different from DPC6484 strain, and no nisin H genes were identified using PCR amplification (data not shown). The *S. hyointestinalis* strain generated broad-spectrum antimicrobial peptides and inhibited various Gram-positive strains ([@r020]). The isolated *S. hyointestinalis* B19 produced bacteriocin containing heat and pH-stable peptides showing activity at all pH and temperature variations experimentally and demonstrated a strong antimicrobial spectrum against a majority of *Clostridium* and *Listeria* species.

The isolated P4 and A3 phages exhibited lytic activity against *C. perfringens* KCTC 3269^T^. Lytic activities of the phages varied with the MOI of the phage and culture conditions. P4 and A3 phages showed the most effective inhibition against *C. perfringens* KCTC 3269^T^.

The combined effects of the isolated bacteriocin and phages were evaluated. Treatment with bacteriocin or phage alone resulted in instant bacteriocidal and bacteriostatic effects against *C. perfringens*, however, regeneration of *C. perfringens* was also observed (data not shown), which was in accordance with previous reports ([@r008]). The most important finding in this study was that a synergistic effect was observed when the phages and bacteriocin were combined. In addition, co-culturing with the bacteriocin-producing *S. hyointestinalis* B19 reduced the population of *C. perfringens* significantly. In addition, the combination of *S. hyointestinalis* B19 and a cocktail of P4 and A3 phages eradicated *C. perfringens* completely. Interestingly, the population of *S. hyointestinalis* B19 in the combined treatment with *C. perfringens* and *S. hyointestinalis* B19 exceeded that of the *S. hyointestinalis* B19 strain inoculated alone.

Finally, the probiotic application of *S. hyointestinalis* B19, acid and bile resistance tests of the strain was evaluated. The *S. hyointestinalis* B19 strain showed tolerance to 3% bile salts and remained stable at pH 4.0.

In conclusion, the isolated bacteriocin and bacteriophages represent potential options for the biocontrol of *C. perfringens*. The bacteriocin-producing *S. hyointestinalis* B19 strain exhibits probiotic effects, with potential application in domestic animals.
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